Oral chemotherapy in paediatric oncology in the UK: problems, perceptions and information needs of parents.
OBJECTIVE
To identify problems, perceptions and information needs of parents and carers regarding oral chemotherapy.


METHODS
Two Paediatric Oncology Centres in the UK.


METHODS
A semi-structured questionnaire was developed in consultation with professionals working within paediatric oncology. Questionnaires were administered in face-to-face interviews with parents of patients attending clinic appointments. Responses to questions were coded and entered into a database for descriptive and inferential analyses. Responses to open questions were coded using simple thematic analysis whereby codes and themes emerged from the data and were compared and contrasted between respondents. Findings were further validated by quotes from interviewees to open questions.


METHODS
Awareness and knowledge of medicines, information needs and handling procedures.


RESULTS
Fifty-five interviews were conducted. Most interviewees viewed oral and intravenous chemotherapy as equally important and potent. Three-quarters of parents were aware of the adverse effects chemotherapy could have on them, worryingly three-quarters of the same group of parents did not use all the handling precaution methods advised by health care professionals. Knowledge of acute lymphoblastic leukaemia maintenance treatment was assessed in 47 interviewees; 31 parents were able to explain the reasons for maintenance chemotherapy. Interviewees felt well informed by the hospital and found it easy to access information they needed. The data suggest the majority of parents had a great interest in understanding the disease and treatment, with 91% using the internet to access further information. Three-quarters of parents faced some kind of difficulty when dealing with oral chemotherapy, including problems with the patient not taking the drug, technical and supply problems and problems following the drug regimen. Self-reported compliance in this study was high with 69.1% of interviewees stating they never forgot a single dose. 72.2% of interviewees used a reminder method, of which 81.6% were written reminders.


CONCLUSIONS
This study highlights that although the support systems offered by the paediatric oncology centres were good, certain areas need improvement, specifically the manner in which parents/carers are educated and informed.
Christiansen
Nanna
N
Pharmacy Department, Royal London Hospital, Pathology and Pharmacy Building, 80 Newark Street, E1 2ES London, UK. nanna.christiansen@bartsandthelondon.nhs.uk
Taylor
Kevin M G
KM
Duggan
Catherine
C
D000284:Administration, Oral; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002173:Cancer Care Facilities; D017028:Caregivers / Q000523:psychology; D002648:Child; D002675:Child, Preschool; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D055118:Medication Adherence / Q000523:psychology; D010290:Parents / Q000523:psychology*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011795:Surveys and Questionnaires; D006113:United Kingdom / Q000453:epidemiology
D000970:Antineoplastic Agents